{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T13:38:07Z","timestamp":1786628287241,"version":"build-2736575974"},"reference-count":23,"publisher":"Scientific Scholar","content-domain":{"domain":["clinicalimagingscience.org"],"crossmark-restriction":true},"short-container-title":["JCIS"],"abstract":"\n Objectives:<\/jats:title>\n To evaluate the effect of COVID-19 on a mobile screening mammography program as measured by turnaround time (TAT) in days between an abnormal screening mammogram (sMG) and diagnostic mammography.<\/jats:p>\n <\/jats:sec>\n \n Material and Methods:<\/jats:title>\n All of our institution\u2019s sMG (mobile and non-mobile) from January 2017, to December 2022 were retrospectively reviewed, and those dated March 7, 2020\u2013July 7, 2020 were excluded because our mobile sMG program was non-operative at that time due to COVID-19. TATs and patient demographics were compared for mobile and non-mobile sMG patients between 2 time periods: Pre-pandemic (January 1, 2017\u2013March 6, 2020) and pandemic (July 8, 2020\u2013December 31, 2022). Statistics included multiple linear regression analysis, Fisher\u2019s Exact, and Wilcoxon Rank Sum tests.<\/jats:p>\n <\/jats:sec>\n \n Results:<\/jats:title>\n \n During the pre-pandemic period, 11,439 female patients (9309 without insurance, 81.3%) underwent 14,161 mobile sMG, while 28,737 female patients (429 without insurance, 1.5%) underwent 57,840 non-mobile sMG. During the pandemic period, 6805 female patients (6720 without insurance, 98.8%) underwent 7663 mobile sMG, while 32,655 female patients (868 without insurance, 2.7%) underwent 53,540 non-mobile sMG. Median TATs for mobile uninsured patients increased from 41 days during the pre-pandemic period to 51 days during the pandemic period (\n p<\/jats:italic>\n < 0.001), while median TATs for non-mobile insured patients decreased from 20 days during the pre-pandemic period to 14 days during the pandemic period (\n p<\/jats:italic>\n < 0.001). Increased TATs were associated with Asian, African American, and Other race compared with White race (Asian,\n p<\/jats:italic>\n = 0.004; African American,\n p<\/jats:italic>\n < 0.001; and Other,\n p<\/jats:italic>\n = 0.02) and self-pay insurance status (\n p<\/jats:italic>\n = 0.006).\n <\/jats:p>\n <\/jats:sec>\n \n Conclusion:<\/jats:title>\n For mobile uninsured screening patients, the number of days between screening and diagnostic mammography increased with the COVID-19 pandemic, while it decreased for non-mobile insured screening patients. Mobile uninsured mammography patients may represent a population that needs additional attention. These findings highlight a health equity concern, as the pandemic disproportionately widened disparities in timely follow-up care for uninsured patients served by mobile mammography programs.<\/jats:p>\n <\/jats:sec>","DOI":"10.25259\/jcis_238_2025","type":"journal-article","created":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T13:04:39Z","timestamp":1786626279000},"page":"31","update-policy":"https:\/\/doi.org\/10.25259\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Follow-up after an abnormal screening mammogram: Impact of a pandemic on mobile mammography patients"],"prefix":"10.25259","volume":"16","author":[{"given":"Ethan Oren","family":"Cohen","sequence":"first","affiliation":[{"name":"Department of Breast Imaging, Division of Diagnostic Imaging, Houston, Texas, United States,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charisma","family":"DeSai","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Division of Diagnostic Imaging, Houston, Texas, United States,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chingyi","family":"Young","sequence":"additional","affiliation":[{"name":"Division of Information Services, Department of Enterprise Data Engineering, and Analytics, Houston, Texas, United States,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, Texas, United States,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary J","family":"Whitman","sequence":"additional","affiliation":[{"name":"Department of Breast Imaging, Division of Diagnostic Imaging, Houston, Texas, United States,"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10894","published-online":{"date-parts":[[2026,8,13]]},"reference":[{"key":"10.25259\/JCIS_238_2025\/ref-2","doi-asserted-by":"publisher","first-page":"e1544","DOI":"10.1002\/hsr2.1544","article-title":"The WHO has declared the end of pandemic phase of COVID-19: Way to come back in the normal life","volume":"6","author":"Sarker","year":"2023","journal-title":"Health Sci Rep"},{"key":"10.25259\/JCIS_238_2025\/ref-3","doi-asserted-by":"publisher","first-page":"e210008","DOI":"10.1148\/ryct.2021210008","article-title":"Axillary lymphadenopathy after mRNA COVID-19 vaccination","volume":"3","author":"Ahn","year":"2021","journal-title":"Radiol Cardiothorac Imaging"},{"key":"10.25259\/JCIS_238_2025\/ref-4","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1148\/radiol.213227","article-title":"Axillary adenopathy after COVID-19 vaccine: No reason to delay screening mammogram","volume":"303","author":"Wolfson","year":"2022","journal-title":"Radiology"},{"key":"10.25259\/JCIS_238_2025\/ref-5","doi-asserted-by":"publisher","first-page":"831","DOI":"10.2214\/AJR.21.25604","article-title":"Management of unilateral axillary lymphadenopathy detected on breast MRI in the Era of COVID-19 vaccination","volume":"217","author":"Edmonds","year":"2021","journal-title":"AJR Am J Roentgenol"},{"key":"10.25259\/JCIS_238_2025\/ref-6","doi-asserted-by":"publisher","first-page":"e200210","DOI":"10.1148\/ryct.2020200210","article-title":"COVID-19: A multimodality review of radiologic techniques, clinical utility, and imaging features","volume":"2","author":"Manna","year":"2020","journal-title":"Radiol Cardiothorac Imaging"},{"key":"10.25259\/JCIS_238_2025\/ref-7","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/j.jacr.2022.04.008","article-title":"Impact of the COVID-19 pandemic on breast imaging: An analysis of the national mammography database","volume":"19","author":"Grimm","year":"2022","journal-title":"J Am Coll Radiol"},{"key":"10.25259\/JCIS_238_2025\/ref-8","doi-asserted-by":"publisher","first-page":"988","DOI":"10.2214\/AJR.21.26890","article-title":"Screening mammography recovery after COVID-19 pandemic facility closures: Associations of facility access and racial and ethnic screening disparities","volume":"218","author":"Lehman","year":"2022","journal-title":"AJR Am J Roentgenol"},{"key":"10.25259\/JCIS_238_2025\/ref-9","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1093\/jbi\/wbaa106","article-title":"Breast cancer screening and the COVID-19 pandemic","volume":"3","author":"Smetherman","year":"2021","journal-title":"J Breast Imaging"},{"key":"10.25259\/JCIS_238_2025\/ref-10","doi-asserted-by":"publisher","first-page":"110419","DOI":"10.1016\/j.clinimag.2025.110419","article-title":"Disparities in breast cancer screening and diagnosis: Urban-Suburban contrasts in the wake of the COVID-19 pandemic","volume":"120","author":"Ciccarelli","year":"2025","journal-title":"Clin Imaging"},{"key":"10.25259\/JCIS_238_2025\/ref-11","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.jacr.2023.06.046","article-title":"Breast imaging patient demographics at a major comprehensive cancer center before and during the COVID-19 pandemic","volume":"21","author":"Cohen","year":"2024","journal-title":"J Am Coll Radiol"},{"key":"10.25259\/JCIS_238_2025\/ref-12","doi-asserted-by":"publisher","first-page":"e2110946","DOI":"10.1001\/jamanetworkopen.2021.10946","article-title":"Socioeconomic and racial inequities in breast cancer screening during the COVID-19 pandemic in Washington State","volume":"4","author":"Amram","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.25259\/JCIS_238_2025\/ref-13","doi-asserted-by":"publisher","first-page":"e230161","DOI":"10.1148\/rycan.230161","article-title":"Long-term mammography screening trends and predictors of return to screening after the COVID-19 pandemic: Results from a statewide registry","volume":"6","author":"Sprague","year":"2024","journal-title":"Radiol Imaging Cancer"},{"key":"10.25259\/JCIS_238_2025\/ref-14","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.clinimag.2021.11.025","article-title":"Barriers to breast cancer screening are worsened amidst COVID-19 pandemic: A review","volume":"82","author":"Tsapatsaris","year":"2022","journal-title":"Clin Imaging"},{"key":"10.25259\/JCIS_238_2025\/ref-15","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1053\/j.sult.2022.11.004","article-title":"The current state of timeliness in the breast cancer diagnosis journey: Abnormal screening to biopsy","volume":"44","author":"Vijayaraghavan","year":"2023","journal-title":"Semin Ultrasound CT MR"},{"key":"10.25259\/JCIS_238_2025\/ref-16","first-page":"162","article-title":"Timing of follow-up after abnormal screening and diagnostic mammograms","volume":"17","author":"Wernli","year":"2011","journal-title":"Am J Manag Care"},{"key":"10.25259\/JCIS_238_2025\/ref-17","doi-asserted-by":"publisher","first-page":"S173","DOI":"10.1016\/j.acra.2020.07.012","article-title":"Retrospective review of a mobile mammography screening program in an underserved population within a large metropolitan area","volume":"29","author":"Spak","year":"2022","journal-title":"Acad Radiol"},{"key":"10.25259\/JCIS_238_2025\/ref-18","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/s00330-021-08117-z","article-title":"Diagnostic interval for non-screening patients undergoing mammography during the COVID-19 pandemic","volume":"32","author":"Crivellaro","year":"2022","journal-title":"Eur Radiol"},{"key":"10.25259\/JCIS_238_2025\/ref-19","author":"D'Orsi","year":"2013"},{"key":"10.25259\/JCIS_238_2025\/ref-20","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.clbc.2023.01.001","article-title":"Delayed diagnosis and prognostic impact of breast cancer during the COVID-19 pandemic","volume":"23","author":"Adachi","year":"2023","journal-title":"Clin Breast Cancer"},{"key":"10.25259\/JCIS_238_2025\/ref-21","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1093\/jnci\/djab097","article-title":"Impact of the COVID-19 pandemic on breast cancer mortality in the US: Estimates from collaborative simulation modeling","volume":"113","author":"Alagoz","year":"2021","journal-title":"J Natl Cancer Inst"},{"key":"10.25259\/JCIS_238_2025\/ref-22","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1002\/cncr.22354","article-title":"Improving follow-up to abnormal breast cancer screening in an urban population. A patient navigation intervention","volume":"109","author":"Battaglia","year":"2007","journal-title":"Cancer"},{"key":"10.25259\/JCIS_238_2025\/ref-23","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.breast.2023.01.001","article-title":"A systematic review of the impact of the COVID-19 pandemic on breast cancer screening and diagnosis","volume":"67","author":"Li","year":"2023","journal-title":"Breast"},{"key":"10.25259\/JCIS_238_2025\/ref-24","doi-asserted-by":"publisher","first-page":"e002482","DOI":"10.1136\/bmjoq-2023-002482","article-title":"Advancing health equity in improving breast cancer screening with the use of a mobile mammography bus in marginalised population: Quality improvement project","volume":"13","author":"Bakhai","year":"2024","journal-title":"BMJ Open Qual"}],"container-title":["Journal of Clinical Imaging Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/clinicalimagingscience.org\/follow-up-after-an-abnormal-screening-mammogram-impact-of-a-pandemic-on-mobile-mammography-patients\/","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/clinicalimagingscience.org\/follow-up-after-an-abnormal-screening-mammogram-impact-of-a-pandemic-on-mobile-mammography-patients\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T13:04:40Z","timestamp":1786626280000},"score":1,"resource":{"primary":{"URL":"https:\/\/clinicalimagingscience.org\/follow-up-after-an-abnormal-screening-mammogram-impact-of-a-pandemic-on-mobile-mammography-patients\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,13]]},"references-count":23,"alternative-id":["10.25259\/JCIS_238_2025"],"URL":"https:\/\/doi.org\/10.25259\/jcis_238_2025","relation":{},"ISSN":["2156-5597","2156-7514"],"issn-type":[{"value":"2156-5597","type":"electronic"},{"value":"2156-7514","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8,13]]},"article-number":"31"}}